ARCHIVES

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

Program Project Guidelines Listed

March 18, 1977

Trials Approved by NCI CTEP For the Month of May

May 25, 2012